At a glance
Read the record in context
Dulaglutide's facts refer to a prefilled presentation and a five-day timing reference. The package example is specifically 0.75 mg in 0.5 mL. The guide does not assign that concentration to every listed strength or treat a pen as a vial waiting for added water.[1]
What the research says
The Trulicity label describes subcutaneous dulaglutide pharmacokinetics in healthy participants and people with type 2 diabetes. Researchers measured circulating drug concentrations and compared exposure across injection sites. The label reports similar pharmacokinetics between these populations and no statistically significant site effect among the studied locations.[2]
Peak concentrations at steady state occurred between 24 and 72 hours, with a median of 48 hours. Elimination half-life was approximately five days. Absolute bioavailability differed between studied strengths, so the document reports the strength alongside each absorption estimate rather than giving one number for every presentation.[2][1]
The label distinguishes directly measured bioavailability at lower strengths from estimates for higher strengths. It also describes degradation through general protein breakdown pathways. These details explain the evidence behind an extended plasma time course while preserving the difference between measured results and extrapolated formulation assumptions.[2]
Cited amounts
The library records 0.75 mg as a labeled package amount. This is the total listed in that presentation, not an amount selected for administration. No personal dosing range is inferred from it.[1][3]
Open the calculator for amount conversionsHalf-life and timing
The 120-hour scalar creates the same numerical halving intervals as another compound with that scalar, but not the same molecule or exposure profile. Here, 240 hours corresponds to 25% and 600 hours to 3.125%. The library separately describes a peak range of 24 to 72 hours and a 48-hour median. Those absorption-related observations are absent from the simple bar. A shared time scale therefore does not establish equal concentrations, matching clinical amounts, or interchangeability with another metabolic compound.[1][5]
Continue to the calculatorReconstitution
For the selected pen presentation, dividing 0.75 mg by 0.5 mL gives 1.5 mg/mL. Multiplying that concentration back by the half-milliliter package volume recovers 0.75 mg, a useful consistency check. A hypothetical 0.1 mL represents 0.15 mg mathematically, but this is not a device-operation instruction. Neither the sample volume nor the calculated mass is selected for administration. The supplied presentation's own instructions remain separate from this exercise in reading concentration units.[3]
Tracking it in PinPoint
From a reference to a record
Built for peptide, TRT, and GLP-1 schedules. Set up your vial in seconds, log every dose, and see your modeled levels between doses. Enter vial size in mg, mcg, or IU and water volume for instant concentration and syringe units. Track vials and prefilled pens side by side.[4]
The Home curve models your levels between doses from published half-life data. Drag to scrub modeled values at any timestamp, or preview 30 days of a dose pattern. Ask PinPoint provides educational reference with sources; it never recommends a dose or a schedule change. These features record and visualize entered information, with the limits of each compound's source data still applying.
Get PinPoint on the App StoreFrequently asked questions
- Is dulaglutide a powder reconstitution example?
- The library identifies a prefilled pen, so the example uses the supplied liquid volume. The 0.75 mg and 0.5 mL figures describe one labeled presentation. They do not create instructions for opening the device, diluting its contents, or selecting an amount.[1][2]
- Why is the dulaglutide example tied to one pen strength?
- The library's package citation specifically describes 0.75 mg in 0.5 mL. Other strengths in the source context do not automatically share that concentration. A conversion based on this example must not silently substitute it for a differently labeled presentation.[1][5]
- Are a median peak time and a half-life the same measurement?
- No. The 48-hour median summarizes the source's peak-timing observations. The 120-hour input is an elimination reference. The bar repeatedly halves an abstract starting quantity and does not model the process that produces the concentration peak.[1][5]
- Can a peptide tracker app record Dulaglutide?
- PinPoint's compound library includes Dulaglutide. The app description covers logging compound, dose, site, and pain level, as well as viewing modeled levels between recorded doses. The curve uses published reference inputs and does not account for individual variation. The tracker records the schedule entered by its user; it does not choose a dose or recommend a schedule change.[1][4]
Sources
Facts and reference links were retrieved from the PinPoint application library on 5 October 2026. Links below preserve the library's citations; a catalog source supports a package amount only. Source references carried from the library have not all been independently reverified. Arithmetic examples are identified separately from clinical evidence.
- PinPoint compound library, DulaglutideSnapshot of the application library; its references and uncertainty are retained below.Retrieved 2026-10-05 · library
- DailyMed prescribing informationIdentity and research summary checked against this document on 5 October 2026. Clinical pharmacology and product-description sections.Retrieved 2026-10-05 · library-reference
- Labeled package referencePackage amount only; not a clinical amount or endorsement.Retrieved 2026-10-05 · label
- PinPoint App Store descriptionFeature wording from the approved application description, not pricing.Retrieved 2026-10-05 · app-description
- Unit conversion and exponential-decay arithmeticC = amount / volume; remaining fraction = 2^(-elapsed / half-life). These are illustrations, not measurements.Retrieved 2026-10-05 · arithmetic